Two approaches to treating schizophrenia, a severe mental disorder that affects an estimated 1 in 100 adults worldwide, receive contrasting evaluations in new studies.
On the disappointing side, patients with schizophrenia who took any of five highly touted antipsychotic drugs for 1 year experienced only modest gains in holding down jobs, sustaining friendships, and otherwise functioning well in daily life.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.